Canadian entrepreneur Cathy Tie, often referred to as 'Biotech Barbie', has declared her intent to genetically modify human embryos, a move that ignites significant ethical and scientific debate. Tie, who once famously attempted to use gene-editing technology to transform horses into unicorns, is now setting her sights on a far more contentious application of the technology.
This ambition is particularly controversial given the history surrounding her ex-husband, He Jiankui, who was jailed for carrying out similar, unsanctioned genetic modifications on human embryos in China. His work, which resulted in the birth of gene-edited twin girls, sparked global condemnation and highlighted the urgent need for stringent ethical guidelines and regulatory oversight in human germline editing.
Tie's current focus brings the complex and often divisive topic of human gene editing back into the spotlight. While somatic gene editing, which affects only the individual treated, holds promise for curing diseases, germline editing, which alters genes in eggs, sperm, or embryos and can be inherited by future generations, is widely considered ethically fraught and is prohibited in many countries, including the UK.
The scientific community largely agrees that human germline editing carries profound risks, including unintended consequences for future generations and the potential for a slippery slope towards 'designer babies'. Regulators worldwide are grappling with how to balance potential therapeutic benefits with the immense ethical and societal implications of such interventions.
In the UK, the Human Fertilisation and Embryology Authority (HFEA) tightly regulates research involving human embryos. While research into gene editing on human embryos is permitted under licence for specific purposes, such as understanding development or infertility, any attempt to implant a genetically modified embryo into a woman is strictly prohibited and illegal. The public and scientific consensus in Britain strongly favours a cautious approach, prioritising safety and ethical considerations above all else.